LBO — WOODLAND HEIGHTS MED CENTER
IRR: 16.0% | MOIC: 2.10x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
16.0%
IRR
2.10x
MOIC
$173.6M
Entry EV
$255.8M
Exit EV
$89.3M
Equity Invested
Sources & Uses
S&UTotal · $173.6M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $67.4M | 38.8% | |
| Sub Debt | $16.9M | 9.7% | |
| Equity | $89.3M | 51.5% | |
| Enterprise Value | $168.5M | 97.1% | |
| Transaction Fees | $5.1M | 2.9% | |
| Total Uses | $173.6M | 100.0% |
Interpretation
INTAt 2.10x MOIC and 16.0% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $24.4M |
| Exit Ev | $255.8M |
| Net Debt At Exit | $67.9M |
| Equity At Exit | $187.9M |
| Equity Invested | $89.3M |
| Total Value Created | $98.6M |
| Value From Growth | $78.9M |
| Value From Multiple | $8.4M |
| Value From Deleveraging | $16.4M |